Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

735.31 +10.44 (+1.44%)
Streaming Delayed Price Updated: 11:04 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year. 
Via Investor's Business Daily
Biotechnology And Healthcare, A Bit Of A Lull
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. 
Via InvestorPlace
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer. 
Via Benzinga
The Best Stocks to Invest $10,000 in Right Now
These elite enterprises can help you grow richer. 
Via The Motley Fool
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
Eli Lilly and Co's Options Frenzy: What You Need to Know
Via Benzinga
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants. 
Via The Motley Fool
Amazon’s AI Awakening: Why AMZN Stock Is the Magnificent Seven’s Sleeping Giant
While garnering relatively less attention than its "Magnificent Seven" peers, AMZN stock is a top buy among this elite set of tech stocks. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Hedge Funds Are Fleeing Tech: 7 Stocks They’re Buying Instead
Although tech remains a hot commodity, these stocks hedge funds are buying suggest that a high-level rotation is occurring. 
Via InvestorPlace
59% of This Vanguard ETF Is Invested in the "Magnificent Seven" Stocks. Is It a No-Brainer Buy Right Now?
If you want to own all of the Magnificent Seven stocks plus other megacap winners, this ETF could be right up your alley. 
Via The Motley Fool
Topics ETFs
SPDR ETF Report For Friday, March 22
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Friday, March 22. 
Via Talk Markets
Topics ETFs
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
The market for weight loss drug stocks is massive, and these three companies could be the biggest beneficiaries of this trend. 
Via InvestorPlace
Don’t Sleep On Global Stocks
ESTX50 and DAX have kept up with SPX over the past three years and six months, even if NDX outpaces them nonetheless. 
Via Talk Markets
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs. 
Via The Motley Fool
Did Eli Lilly Just One-Up Novo Nordisk?
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments. 
Via The Motley Fool
Could Viking Therapeutics Become the Next Eli Lilly?
Viking shares have skyrocketed on its recent good news. 
Via The Motley Fool
Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.
Novo Nordisk's Wegovy recently gained Food and Drug Administration approval to reduce the risk of cardiovascular problems. 
Via Investor's Business Daily
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health
Medicare considers extending coverage for Novo Nordisk's Wegovy to eligible members with heart disease history. CMS may include anti-obesity drugs under certain Medicare Part D plans. Germany's health... 
Via Benzinga
Amazon’s 1-2 Punch: AI-Powered Listings and Eli Lilly Deal Make AMZN a Must-Buy
AMZN stock can easily continue to run higher as Amazon rolls out more AI features and works closely with a famous pharmaceutical giant. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions
Eli Lilly stock is up 32% so far in 2024 and has risen 318% over three years. 
Via Benzinga
Healthcare And Biotech Update With Market At 2024 Highs
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD. 
Via Talk Markets
Wall Street’s Favorite Tech Stocks? 3 Names That Could Make You Filthy Rich
Bet on success with Wall Street's favorite tech stocks. These investments have the potential to outperform the market. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?
The gap has been shrinking between these stocks over the past month. 
Via The Motley Fool
3 Stocks Ready to Ride the Bull Higher
Each of these securities is rising on strong earnings prints and catalysts that could send their share prices upwards in coming months. 
Via InvestorPlace
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys. 
Via InvestorPlace
Visualizing The Biggest Companies On Major Stock Exchanges
The NYSE’s largest companies are more diversified, with a combination of tech, financial services, and healthcare names present. 
Via Talk Markets
What Retail Apocalypse? 7 Stocks Proving the Doomsayers Wrong.
People have said retail is dying for years now but the supposed apocalypse is nowhere to be found with these fast-charging retail stocks. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.